Advancing Neuroimmunology Drug Discovery with iPSC Derived Microglia & Oligodendrocytes
Time: 9:00 am
day: Conference Day Two
Details:
- BrainXell company overview
- Current portfolio of iPSC derived neurons and glia
- New product highlight: Oligodendrocytes
- Disease models and edited lines
- Custom production capabilities
